Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Xilio Therapeutics (XLO) Other Gross PP&E Adjustments (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Other Gross PP&E Adjustments for 2 consecutive years, with $6.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 9.75% to $6.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2025, up 9.75% year-over-year, with the annual reading at $6.5 million for FY2025, 9.75% up from the prior year.
  • Other Gross PP&E Adjustments hit $6.5 million in Q4 2025 for Xilio Therapeutics, down from $6.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $7.0 million in Q2 2025 to a low of $5.9 million in Q4 2024.